Diagnosed congenital hypothyroidism with missing follow-up: is it time for a national registry?

Ibrahim Al-Alwan1, Ibrahim Al-Alwani, Ahlam AlRowaeah

  • 1College of Medicine, King Saud bin Abdulaziz University for Health Sciences PO Box 3660, MC 3133, Riyadh 11481, Saudi Arabia. alwani@ngha.med.sa

Annals of Saudi Medicine
|February 12, 2013
PubMed

Insights

Congenital hypothyroidism (CH) screening is vital, but lost follow-up can lead to intellectual disability and short stature. A patient registry is recommended to improve monitoring and outcomes for CH.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Screening
  • Metabolic Disorders

Background:

  • Congenital hypothyroidism (CH) is a treatable cause of mental retardation.
  • Neonatal screening programs aim to detect CH early for timely intervention.

Observation:

  • A 17-year-old male diagnosed with CH via newborn screening had an ectopic thyroid gland.
  • Treatment was initially discontinued by the family, with follow-up delayed until age 11.
  • Despite re-initiation of thyroxine and normalized thyroid function, the patient experienced short stature and impaired IQ.

Findings:

  • Delayed and inconsistent follow-up care significantly impacted the long-term neurodevelopmental and physical outcomes in a patient with congenital hypothyroidism.
  • Even with early diagnosis, lapses in patient adherence and monitoring systems can lead to irreversible complications.

Implications:

  • Highlights the critical need for robust patient follow-up systems in managing congenital hypothyroidism.
  • Suggests the implementation of a patient registry for congenital hypothyroidism to enhance care monitoring and evaluate screening program efficacy.
  • Emphasizes the importance of patient and family education regarding lifelong management of CH.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...